Molecular Heterogeneity in Cystic Fibrosis

Abstract

We aimed to evaluate type, frequency, and variety of pathogenic variants according to clinical and demographic features of children diagnosed with cystic fibrosis (CF). Twenty-five CF patients were evaluated retrospectively. Patients' demographics, physical examination, imaging, laboratory, and molecular pathogenic variant analysis findings were evaluated. Phe508del was the most frequently (33.3%) detected pathogenic variant, followed by point pathogenic variants E92K, 1898 + lGA/7T/7T, and 2789 + 5GA, respectively. Statistically higher rates of pathogenic variants were detected in male patients. The most frequently detected pathogenic variant was Phe508del. The identification of nine additional pathogenic variants of Phe508del revealed the heterogeneous nature of the CF.

Keywords

cystic fibrosis transmembrane conductance regulator - cystic fibrosis - Phe508del

Note

Institutional Review Board protocol approval number: 2019/13; Institutional Review Board protocol approval date: February 2, 2019. Informed consent was obtained from all individual participants included in the study.

• References

• 1 Farrell PM, White TB, Howenstine MS. , et al. Diagnosis of cystic fibrosis in screened populations. J Pediatr 2017; 181S: S33-S44 , 44.e2
• 2 Quon BS, Rowe SM. New and emerging targeted therapies for cystic fibrosis. BMJ 2016; 352: i859
• 3 Castellani C, Assael BM. Cystic fibrosis: a clinical view. Cell Mol Life Sci 2017; 74 (01) 129-140
• 4 Cutting GR, Engelhardt J, Zeitlin PL. Genetics and pathophysiology of cystic fibrosis. In: Wilmott RW, Deterding R, Li A. , et al, eds. Kendig's Disorders of the Respiratory Tract in Children. 9th ed. Philadelphia, PA: Elsevier; 2019: 757-768
• 5 Stephenson AL, Tom M, Berthiaume Y. , et al. A contemporary survival analysis of individuals with cystic fibrosis: a cohort study. Eur Respir J 2015; 45 (03) 670-679
• 6 Castellani C, Massie J, Sontag M, Southern KW. Newborn screening for cystic fibrosis. Lancet Respir Med 2016; 4 (08) 653-661
• 7 Raraigh KS, Pastore MT, Greene L. , et al. Diagnosis and treatment of cystic fibrosis: a (not-so) simple recessive condition. Curr Genet Med Rep 2017; 5 (02) 91-99
• 8 Stephenson AL, Stanojevic S, Sykes J, Burgel PR. The changing epidemiology and demography of cystic fibrosis. Presse Med 2017; 46 (6, Pt 2): e87-e95
• 9 MacKenzie T, Gifford AH, Sabadosa KA. , et al. Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry. Ann Intern Med 2014; 161 (04) 233-241
• 10 Mehta G, Macek Jr M, Mehta A. ; European Registry Working Group. Cystic fibrosis across Europe: EuroCareCF analysis of demographic data from 35 countries. J Cyst Fibros 2010; 9 (Suppl. 02) S5-S21
• 11 Stick SM, Brennan S, Murray C. , et al; Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF). Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 2009; 155 (05) 623-8.e1
• 12 Gangell C, Gard S, Douglas T. , et al; AREST CF. Inflammatory responses to individual microorganisms in the lungs of children with cystic fibrosis. Clin Infect Dis 2011; 53 (05) 425-432
• 13 Debray D, Kelly D, Houwen R, Strandvik B, Colombo C. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J Cyst Fibros 2011; 10 (Suppl. 02) S29-S36
• 14 Kobelska-Dubiel N, Klincewicz B, Cichy W. Liver disease in cystic fibrosis. Prz Gastroenterol 2014; 9 (03) 136-141
• 15 Monti L, Manco M, Lo Zupone C. , et al. Acoustic radiation force impulse (ARFI) imaging with Virtual Touch Tissue Quantification in liver disease associated with cystic fibrosis in children. Radiol Med (Torino) 2012; 117 (08) 1408-1418
• 16 Hall WB, Sparks AA, Aris RM. Vitamin d deficiency in cystic fibrosis. Int J Endocrinol 2010; 2010 (01) 218691
• 17 Boyle MP, Noschese ML, Watts SL, Davis ME, Stenner SE, Lechtzin N. Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis. Am J Respir Crit Care Med 2005; 172 (02) 212-217
• 18 Rovner AJ, Stallings VA, Schall JI, Leonard MB, Zemel BS. Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation. Am J Clin Nutr 2007; 86 (06) 1694-1699
• 19 Sapiejka E, Krzyżanowska P, Walkowiak D. , et al. Vitamin A status and its determinants in patients with cystic fibrosis. Acta Sci Pol Technol Aliment 2017; 16 (03) 345-354
• 20 Pankow S, Bamberger C, Calzolari D. , et al. ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. Nature 2015; 528 (7583): 510-516
• 21 Santos CD, Steemburgo T. Nutrional status and dietary factors in cystic fibrosis patients with delta F508 mutation. Rev Nutr 2015; 28 (04) 359-369
• 22 Radivojevic D, Djurisic M, Lalic T. , et al. Spectrum of cystic fibrosis mutations in Serbia and Montenegro and strategy for prenatal diagnosis. Genet Test 2004; 8 (03) 276-280
• 23 Stepanova AA, Abrukova AV, Savaskina EN, Poliakov AV. Mutation p.E92K is the primary cause of cystic fibrosis in Chuvashes. Russ J Genet 2012; 48: 731-737
• 24 Kitzis A, Chomel JC, Kaplan JC. , et al. Unusual segregation of cystic fibrosis allele to males. Nature 1988; 333 (6170): 215-222